Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-017636

Director sold 19,232 shares at an average $36.98 ($711,199)

  • Director acquired 72,016 shares (option exercise)
  • Director gave up 3,778 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-07 Exercise or conversion : show line 1 in the form +41,152 $2.68 $110,287 47,152 D
2023-03-07 Shares withheld for taxes : show line 2 in the form −2,160 $37.13 $80,201 44,992 D
2023-03-07 Sale : show line 3 in the form −10,990 $37.01 $406,740 34,002 D
2023-03-07 Exercise or conversion : show line 4 in the form +30,864 $2.59 $79,938 64,866 D
2023-03-07 Shares withheld for taxes : show line 5 in the form −1,618 $37.13 $60,076 63,248 D
2023-03-07 Sale : show line 6 in the form −8,242 $36.94 $304,459 55,006 D
Open-market sales · 19,232 sh · avg $36.98 · $711,199

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-07 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −41,152 0 D
2023-03-07 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −30,864 0 D
Loading xslF345X03/doc4.xml…